BOCHK Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.93M Buy
6,610
+2,610
+65% +$2.67M 1.25% 24
2026
Q1
$3.68M Buy
4,000
+3,000
+300% +$3.04M 0.76% 39
2025
Q4
$1.07M Buy
1,000
+684
+216% +$654K 0.29% 31
2025
Q3
$241K Sell
316
-184
-37% -$137K 0.06% 59
2025
Q2
$390K Buy
+500
New +$389K 0.11% 30
2024
Q4
Sell
-11,900
Closed -$10.5M 76
2024
Q3
$10.5M Sell
11,900
-3,150
-21% -$2.83M 3.14% 11
2024
Q2
$13.6M Buy
15,050
+3,100
+26% +$2.48M 4.46% 8
2024
Q1
$9.3M Buy
11,950
+900
+8% +$641K 3.25% 10
2023
Q4
$6.44M Buy
+11,050
New +$6.45M 3.96% 8

Other funds holding LLY

BOCHK Asset Management's LLY Position: Q2 2026 in Review

BOCHK Asset Management increased its Eli Lilly (LLY) stake by 65% in Q2 2026, buying an estimated $2.67M and bringing the position to 6,610 shares worth $7.93M. The position accounts for 1.25% of the portfolio, ranked #24.

BOCHK Asset Management first reported a position in LLY in Q4 2023 and has held it in 9 quarters since. The position peaked at $13.6M in Q2 2024. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BOCHK Asset Management held 6,610 shares of Eli Lilly worth $7.93M as of Q2 2026.
  • BOCHK Asset Management bought 2,610 Eli Lilly shares in Q2 2026, an estimated $2.67M.
  • Eli Lilly made up 1.25% of BOCHK Asset Management's portfolio in Q2 2026, its #24 holding.
  • BOCHK Asset Management first reported a position in Eli Lilly in Q4 2023 and has held it in 9 quarters since.
  • BOCHK Asset Management's Eli Lilly position peaked at $13.6M in Q2 2024.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BOCHK Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.